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The change in differing leukocyte populations during vaccination to bovine respiratory 
disease and their correlations with lung scores, health records, and average daily gain1,2,3
R. J. Leach,*4 C. G. Chitko-McKown,* G. L. Bennett,* S. A. Jones,*  
S. D. Kachman,† J. W. Keele,* K. A. Leymaster,* R. M. Thallman,* and L. A. Kuehn*
*ARS-USDA, U.S. Meat Animal Research Center, Clay Center, NE 68933; and
†Department of Statistics, University of Nebraska–Lincoln, Lincoln 68583
ABSTRACT: Bovine respiratory disease (BRD) is 
the most economically important disease in U.S. feed-
lots. Infection can result in morbidity, mortality, and 
reduced average daily gain. Cheap and reliable genetic 
methods of prediction and protection from BRD would 
be highly advantageous to the industry. The immune 
response may correlate with BRD incidence. Cattle (n 
= 2,182) were vaccinated against common viral and 
bacterial pathogens of BRD. Two blood samples were 
collected, one during booster vaccination and one 21d 
later, enabling 3 phenotypes for each trait [prebooster 
(pre), postbooster (post), and delta (post minus pre)]. 
From the blood samples innate and adaptive responses 
[counts of white blood cells (WBC), neutrophils, lym-
phocytes, monocytes, eosinophils, and basophils] were 
measured. In addition, feedlot ADG and binary traits 
[health records (HR; 0 = healthy, 1 = ill) and lung scores 
(LS; collected at harvest; 0 = no lesions, 1 = lesions)] 
were also recorded. Traits ADG, HR, and LS have all 
been significantly correlated with infection to BRD. In 
this investigation we aimed to find correlations between 
the immune response and ADG, HR, and LS to find an 
easily measurable trait that would be a good predictor of 
BRD resistance after vaccination. The results showed an 
average positive delta for the innate immune response 
(eosinophils, basophils, neutrophils), whereas the adap-
tive immune response had an average negative delta 
(lymphocytes). Overall, we discovered that the immune 
responses had moderately high heritabilities (h2; lowest: 
delta monocytes, 0.21 ± 0.05; greatest: pre lympho-
cytes: 0.5 ± 0.05), with lymphocytes having the greatest 
h2 throughout the study (h2 ≥ 0.41). All genetic corre-
lations were calculated using bivariate REML models. 
Although LS did not significantly correlate with any 
of the immune phenotypes, both ADG (post lympho-
cytes, -0.24 ± 0.12) and HR (pre eosinophils, -0.67 ± 
0.29; delta WBC, -0.5 ± 0.24, and delta lymphocytes, 
-0.67 ± 0.21) did. All the significant genetic correlations 
with HR were negative; resistance to BRD appears to 
be a function of greater delta lymphocytes and WBC. 
The increase in eosinophils may potentially link its role 
in decreasing lymphocytes. These results may enable 
producers to predict if revaccination, quarantine, and 
breeding of animals is required to reduce the incidence 
of BRD postvaccination. In addition, immunological 
phenotypes maybe used to aid genomic selection indices 
to select animals with greater rates of protection after 
BRD vaccination.
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InTRoDuCTIon
Bovine respiratory disease (BRD) is the most 
costly disease in U.S. beef cattle; infection can result 
in morbidity, mortality, and reduced ADG, causing 
the value of a carcass to decrease (Irsik et al., 1996; 
Griffin, 1997; Fulton, 2009). When treatment is also 
considered, costs can increase rapidly (McNeill et al., 
1996; Faber et al., 1999). The estimated heritability of 
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BRD is low (Muggli-Cockett et al., 1992; Snowder et 
al., 2005; Schneider et al., 2010); however, it is like-
ly underestimated because of field and observational 
phenotypes being used (Bishop and Woolliams, 2010). 
Because of direct and indirect costs associated with 
treating BRD infection, methods to genetically select 
or manage animals for increased resistance would be 
beneficial. By concentrating on correlated component 
traits, methods such as breeding for increased disease 
resistance and genetic prediction are possible.
The immune response is highly complex with many 
components of both the innate and adaptive respons-
es needed to confer immunity after infection or vac-
cination. White blood cell counts (WBC) and counts 
of white blood cell types (neutrophils, lymphocytes, 
monocytes, eosinophils, and basophils) are objective 
measures of innate or adaptive immunity. Measurement 
of these immune response variables in response to re-
spiratory disease vaccinations could provide an objec-
tive measure for the potential of an animal for resis-
tance to BRD.
Lung score (LS), health records (HR), and ADG 
have all been used as measures or correlates of BRD 
incidence (Wittum et al., 1996; Thompson et al., 2006; 
Schneider et al., 2009). Thus, we investigated all 3 
for potential genetic correlations with the immune re-
sponse. Correlated traits would allow us to understand 
if the immune response at the end of vaccination is in-
dicative of resistance to BRD or changes in ADG.
Within this study we show that the immune traits 
(blood phenotypes) change significantly during the 
time course. We also discover significant correlations 
between the blood phenotypes and ADG, HR, and LS.
MATeRIALS AnD MeTHoDS
Animals were raised in conformation with the 
Guide for the Care and Use of Agricultural Animals 
in Agricultural Research and Teaching (FASS, 1999), 
and their care was approved by the U.S. Meat Animal 
Research Center (uSMARC) Animal Care and Use 
Committee.
Phenotypes were collected from 2,182 cattle born 
in 2008, 2009, and 2010 from the USMARC Germ 
Plasm Evaluation (GPe) herd. The phenotypes were 
measured at 2 time points during vaccination with 2 
multipurpose vaccines. The vaccines offered protec-
tion against both viral (BRSV, IBR, PI3, BVD I, and 
BVD II) and bacterial (such as Pasteurella haemolyt-
ica) components of BRD. The measured phenotypes 
were the counts, within whole blood, of WBC, neutro-
phils, lymphocytes, monocytes, eosinophils, and baso-
phils. In addition to the blood-based phenotypes, HR, 
LS, and feedlot ADG were also measured.
Animals and Pedigree
Data were collected from animals in advanced gener-
ations of the USMARC GPE herd, Clay Center, Nebraska. 
This particular GPE subset was a product of multiple-sire 
matings of crossbred cows to F1 bulls of varying half-
blood composition. The resulting animals used within this 
study consisted of variable fractions of 9 breeds: Angus, 
Hereford, Red Angus, Brahman, Charolais, Gelbvieh, 
Limousine, Simmental, and MARCIII composite (1/4 
Angus, 1/4 Hereford, 1/4 Red Poll, 1/4 Pinzgauer).
As part of a separate project, calves were geno-
typed for approximately 50,000 SNP markers using the 
Illumina BovineSNP50 (Illumina Inc., San Diego, CA). 
Resulting genotypes were used to assign sires to their 
progeny. By subtracting the genotypes of the candidate 
animal with each potential parent (in a stepwise man-
ner), the parent of the candidate animal can be predicted; 
smaller values (when all 50,000 SNP differences are 
summed) indicate paternity. We excluded paternity if 
values were greater than 0.05%. If more than 1 sire was 
eligible, the sire with the smallest value was chosen.
Vaccination Schedule
Initial vaccination was at prebreeding (average age = 
60 d). The booster vaccination was administered at pre-
conditioning. The average age of the calves at the boost-
er vaccination was 139 d (with a SD of 17 d).
All animals were vaccinated in accordance with the 
manufacturer’s guidelines. Each animal was adminis-
tered 2 mL intramuscularly (for both initial and booster 
vaccinations) of Merck Vista 5 SQ and Vista Once SQ 
(years 2008 and 2009; Merck Inc., Summit, NJ) or Pfizer 
Bovi-Shield Gold 5 and One Shot Ultra 8 (animals born 
in 2010; Pfizer Inc., New York, NY). The vaccines used 
offered protection from common viral and bacterial 
components that cause BRD. Only One Shot Ultra 8 
contained an adjuvant, Stimugen (Pfizer Inc.).
Phenotypes
Binary Traits. Both HR and LS were analyzed as bi-
nary threshold traits. The HR were collected from weaning 
(165 ± 17 d) to slaughter. The monitoring period for BRD 
began when animals were weaned into the USMARC 
feedlot 21 d after the booster vaccination. Animals were 
not given therapeutic antibiotics during the feeding pe-
riod, unless there was an outbreak situation. All animals 
were monitored for respiratory disease and illness by 
trained cattlemen; cattle were diagnosed on the basis of 
the observation of multiple symptoms, including lethargy, 
nasal discharge, isolation from other animals, respiration 
rate, and body temperature (after being removed from pen 
for treatment). Cattle not diagnosed with BRD-like symp-
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toms between vaccination and slaughter were coded as 0 
for analysis. Cattle that had symptoms sufficient for BRD 
diagnosis postweaning were assigned a 1.
Lung scores were conducted by observing the percent-
age of the lung surface containing lung lesions postmortem 
(similar to the system designed by D. Griffin, University 
of Nebraska–Lincoln, personal communication). Briefly, 
lungs were inspected visually at an abattoir at line speed 
(~360 carcasses/h) by a veterinarian trained to observe lung 
lesions. Although lungs were scored on a multipoint scale 
depending on severity (percent of lung with lesions), pre-
liminary analyses showed no additional information was 
garnered by analyzing the multinomial scale. Therefore, all 
animals with any lung lesions were coded as a 1, whereas 
animals with no lesions present were coded as 0.
Average Daily Body Weight Gain. The ADG was cal-
culated as the linear regression coefficient of BW on age of 
the animal at multiple time points (at least 3 time points for 
each animal) from weaning through final (preharvest) BW.
Blood Collection and Blood Analysis. Initial blood 
samples (25 mL) were collected concurrently with the 
administration of the first booster vaccination at precon-
ditioning. A second blood sample (25 mL) was collected 
21 d later at weaning. Whole blood was collected by 
jugular venipuncture, and 1 mL was deposited into 2-mL 
screw cap tubes containing potassium EDTA as an anti-
coagulant. Before analysis on a Hemavet CDC Mascot 
veterinary hematology analyzer (CDC Technologies, 
Oxford, CT), the samples were brought to room tempera-
ture and stirred for at least 15 min. Data from the analy-
ses were transferred to spreadsheets using WinWedge 
Pro software (Taltech Inc., Philadelphia, PA). Delta 
measurements were obtained from the subtraction of 
the prebooster phenotypes from the postbooster pheno-
types. Measurements of WBC, neutrophils, lymphocytes, 
monocytes, eosinophils, and basophils were used as phe-
notypes (all measured in k/μL). Red blood cell pheno-
types were also measured but not used as an indicator of 
immune function.
Statistical Analysis
Software (ASREML; Gilmour et al., 2009) was used 
for REML estimates of all (co)variance components. 
Heritability for each trait was estimated using a univari-
ate REML model. For all traits, the model included birth 
location and mating group by year of birth (CG) and sex 
(S) as fixed effects; β1, the linear regression on the ex-
pected level of heterosis h (heterosis: min = 0, max = 1, 
average = 0.78); β2, the linear regression on birth date 
b; a, the random effect of animal, a ~ N(0, Aσ2g), where 
A is the numerator relationship matrix; and eijk, the re-
sidual error, e ~ N(0, Iσ2p):
Yijk = µ + CGi + Sj + β1h + β2b + ak + eijk.
Breed composition was included in the model us-
ing genetic founder group effects (Westell et al., 1988). 
Bivariate REML models were used to calculate the ge-
netic correlations between ADG, HR, and LS with the 
blood phenotypes. Because of the binary nature of HR 
and LS, a probit link function was used; to estimate the 
genetic correlation of these 2 traits, 1 of the 2 variables 
was fitted as linear. As results did not vary on the basis 
of which trait was linear, we show results from fitting LS 
as linear. The same fixed effects were fitted in bivariate 
models and univariate models. Relationships among the 
delta measurements were derived using a 6-trait multi-
variate model. A t test using the SE of the correlation co-
efficient was used to calculate the correlation P-values.
ReSuLTS
Trait Overview
The blood phenotypes are summarized in Table 1, 
with “pre” phenotypes highlighting concentrations at 
the point of booster vaccination and “post” phenotypes 
highlighting concentrations at 21 d after booster vacci-
nation. Although the delta measurements (post pheno-
type minus pre phenotype; Table 1) are small and even 
negative (with 2 of the 6 showing a decrease), t tests 
show highly significant differences between pre vs. post 
(P < 0.01), with the exceptions of WBC and monocytes, 
which were not significant (P > 0.05). Average ADG 
was 3.15 (SD = 0.49), whereas HR and LS had averages 
of 0.13 and 0.79, respectively.
Table 2 shows the means for each blood phenotype 
measure relative to HR and LS. All the phenotypes that 
are significantly different for HR are also significantly 
different when grouped by lung score (pre and delta 
lymphocytes and pre and post basophils; Table 2). In ad-
dition, the concentrations of pre WBC and delta WBC 
are also significantly different between the groupings of 
Table 1. Means and SD of traits measured pre- and post-
booster vaccination and the changes between them (delta)
 
Trait1
Prebooster  Postbooster  Delta
Mean SD Mean SD Mean SD
WBC 10.44 2.76 10.39 2.24 -0.04 2.76
NE* 2.89 1.25 3.03 1.16 0.15 1.42
LY* 5.97 1.74 5.5 1.34 -0.47 1.54
MO 0.65 0.27 0.64 0.23 0 0.30
EO* 0.89 0.50 1.15 0.60 0.26 0.67
BA* 0.04 0.05 0.07 0.09 0.03 0.10
1Traits are white blood cells (WBC), neutrophils (NE), lymphocytes (LY), 
monocytes (MO), eosinophils (EO), and basophils (BA). An asterisk (*) next 
to the trait name indicates that the pre- and postbooster phenotype measure-
ments are significantly different (P < 0.01).
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lung scores (Table 2). The counts for each phenotype, 
split by HR and lung score, are also shown in Table 2, 
where the minimum count for HR was 227 (HR = 1, pre 
phenotypes). The minimum count for lung score was 
429 (lung score = 0, pre phenotypes).
The counts for the 2 binary traits combined are shown 
in Table 3. It would appear that the diagnosis of a healthy 
animal with no BRD was accurate during this study. 
Accordingly, 86.1% of animals that did not have lung le-
sions had no previous diagnosis. Indeed, of those diag-
nosed, 76.5% had lung lesions. However, the specificity 
of the lung lesions as a measure of clinical BRD symp-
toms appeared low, as animals with lung lesions generally 
had no diagnosis records (87.7%, Table 3). The 2 traits 
(LS and HR) are very poor predictors of each other.
Heritability
Heritability was calculated for each blood phenotype 
as well as ADG, HR, and LS (Table 4). A wide range 
of heritabilities was observed in this study (Table 4). 
The greatest heritability estimated for the pre, post, and 
delta phenotypes was pre lymphocytes [h2 = 0.5 (0.07); 
Table 4], whereas the smallest was delta monocytes [h2 = 
0.21 (0.05); Table 4]. The concentration of lymphocytes 
in the whole blood appears to be the most consistently 
heritable phenotype measured throughout the booster 
vaccination. Its heritability was estimated above 0.4 for 
the pre, post, and delta phenotypes. In general, heritability 
is lower for the delta phenotypes. Lung score and HR both 
had low heritabilities (h2 for both <0.1; Table 4), whereas 
ADG had a moderately high heritability [h2 = 0.44 (0.07)].
Genetic Correlations
To discover the role of the additive genetic variation 
in maintaining increased concentrations of the blood 
phenotypes during the booster, genetic correlations 
were calculated between the pre and post phenotypes 
(Table 5). All of the correlations, with the exception of 
Table 2. Mean and standard deviation for blood phenotypes measured pre- and postbooster vaccination and the 
changes between them (delta) when separated by health record and lung score categories
 
Trait1
Health Records  
 
Lung Score
02 SD3 14 SD 0 vs. 15 0 SD 1 SD 0 vs. 1
Pre_WBC 10.40 (1,882) 2.83 10.68 (277) 2.24 10.67 (429) 2.16 10.32 (1,573) 2.95  <0.01
Post_WBC 10.43 (1,887) 2.25 10.19 (283) 2.15 10.38 (432) 2.32 10.43 (1,584) 2.12
Delta_WBC 0.06 (1,897) 3.06 -0.27 (284) 2.89 -0.22 (433) 2.42 0.19 (1,590) 3.43  <0.01
Pre_NE 2.88 (1,882) 1.25 2.93 (277) 1.23 2.89 (429) 1.16 2.88 (1,573) 1.39
Post_NE 3.05 (1,887) 1.15 2.94 (283) 1.19 3.01 (432) 1.20 3.05 (1,584) 1.09
Delta_NE 0.17 (1,897) 1.47 0.07 (284) 1.40 0.14 (433) 1.33 0.19 (1,590) 1.61
Pre_LY 5.93 (1,882) 1.76 6.22 (277) 1.57  <0.01 6.24 (429) 1.47 5.89 (1,573) 1.67  <0.01
Post_LY 5.51 (1,887) 1.34 5.46 (283) 1.37 5.54 (432) 1.36 5.50 (1,584) 1.25
Delta_LY -0.40 (1,897) 1.71 -0.63 (284) 1.64  <0.05 -0.65 (433) 1.39 -0.35 (1,590) 1.64  <0.01
Pre_MO 0.65 (1,882) 0.27 0.63 (277) 0.22 0.62 (429) 0.22 0.64 (1,573) 0.32
Post_MO 0.64 (1,887) 0.23 0.64 (283) 0.22 0.63 (432) 0.22 0.65 (1,584) 0.22
Delta_MO 0.00 (1,897) 0.31 0.02 (284) 0.29 0.01 (433) 0.24 0.02 (1,590) 0.40
Pre_EO 0.90 (1,882) 0.50 0.87 (277) 0.48 0.88 (429) 0.39 0.86 (1,573) 0.64
Post_EO 1.15 (1,887) 0.61 1.09 (283) 0.54 1.14 (432) 0.58 1.16 (1,584) 0.56
Delta_EO 0.26 (1,897) 0.68 0.24 (284) 0.62 0.26 (433) 0.60 0.30 (1,590) 0.79
Pre_BA 0.042 (1,882) 0.06 0.035 (277) 0.03  <0.01 0.03 (429) 0.04 0.04 (1,573) 0.09  <0.05
Post_BA 0.07 (1,887) 0.09 0.06 (283) 0.07  <0.05 0.06 (432) 0.08 0.07 (1,584) 0.07  <0.05
Delta_BA 0.03 (1,897) 0.10 0.02 (284) 0.07 0.03 (433) 0.08 0.03 (1,590) 0.10
1All names have been standardized. Abbreviations of traits are white blood cells (WBC), neutrophils (NE), lymphocytes (LY), monocytes (MO), eosinophils 
(EO), and basophils (BA), where pre_ = trait measured when booster vaccinations were administered, post_ = trait measured 21 d after booster vaccinations, and 
delta_ = post time point minus pre time point.
2Here 0 = the mean average of all animals with a 0 for diagnosis (animal remained healthy after vaccination) or lung lesion (no damage to lung). The number 
in parentheses is the number of animals used to make the observation.
3The SD of the measured trait.
4Here 1 = the mean average of all animals with a 1 for diagnosis (animal diagnosed with respiratory illness after vaccination) or lung lesion (damage to lung). 
The number in parentheses is the number of animals used to make the observation.
5Here 0 vs. 1 = P-value from a 2-tailed t test between 0 and 1 of diagnosis or lung lesion. If no value is entered, P > 0.05.
Table 3. Counts of the number of animals with different 
lung scores cross classified with health records
 
Health Records
Lung Score
0 1 Total
0 373 1395 1,768
1 60 195 255
Total 433 1590 2,023
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basophils, differed from 0 (P < 0.05). The 3 greatest cor-
relations of WBC, neutrophils, and lymphocytes (0.64 ± 
0.07, 0.73 ± 0.08, and 0.67 ± 0.06, respectively; Table 5) 
were highly significant (P < 0.01). Although the average 
WBC and the lymphocytes delta measurements are neg-
ative, they show positive genetic correlations between 
the pre and post measurements (Tables 1 and 5).
Genetic correlations were estimated (Table 6) be-
tween all of the blood phenotypes with ADG, HR, and 
LS. Of the estimated correlations, 4 were significant 
(t test; P <  0.05; Table 6). The majority of pheno-
types (with the exceptions of pre neutrophils, post eo-
sinophils, delta monocytes, delta eosinophils, and HR) 
were negatively correlated with ADG. However, the 
only 1 of these correlations that was significant was 
between ADG and post lymphocytes (-0.24 ± 0.12), in-
dicating that ADG decreased as post lymphocytes con-
centrations increased. No significant correlations ex-
isted between any blood phenotype and LS. However, 
3 phenotypes were significantly correlated with HR 
(pre eosinophils, delta WBC, and delta lymphocytes; 
Table 6). The greatest correlation was significant with a 
P-value of less than 0.01 (delta lymphocytes), whereas 
the other 2 had P-values of 0.05 or better (pre eosino-
phils, delta WBC).
When compared, the genetic correlations of the phe-
notypes with HR vs. with LS have little similarity. Ten 
of the 18 correlations calculated did not change direc-
tion when the same trait was correlated with HR as op-
posed to LS (Table 6). However, large SE are present, 
and little genetic correlation exists between the 2 binary 
traits (0.16 ± 0.6; Table 6), highlighting the differing 
magnitudes of correlation between the measured pheno-
types and the 2 binary traits.
Genetic correlations of the delta blood phenotypes 
are summarized in Table 7. In general, the blood phe-
notypes were highly correlated, with 10 of the 15 pos-
sible correlations being significant (P < 0.05). With the 
exception of basophils vs. neutrophils and lymphocytes, 
all of the significant correlations were positive.
Breed Differences
The models used during this study estimated the ef-
fects of each breed in the GPE herd. All breeds showed 
similar effects throughout the study (Table 8), with few 
being significantly different from the others for any trait. 
A notable exception is the Bos indicus breed, Brahman, 
which was significantly different from the other breeds 
throughout various phenotypes. From all the breeds that 
compose the GPE herd, Brahman and Hereford elicited 
significantly different phenotypes the most frequently. 
No other breeds were significantly different from each 
other. In addition, the results indicated that no breed had 
a significant effect on ADG, diagnosis, or lung lesion.
Table 4. Heritabilities and additive variance for blood phenotypes measured pre- and postbooster vaccination and the 
changes between them (delta) and ADG, health records, and lung scores
 
Trait1
Prebooster  Postbooster  
 
Delta
h2 SE Add_Var2 SE h2 SE Add_Var SE h2 SE Add_Var SE
WBC 0.47 0.06 3.28 0.52 0.47 0.07 2.28 0.38 0.35 0.06 2.34 0.43
NE 0.44 0.06 0.68 0.11 0.41 0.06 0.55 0.1 0.24 0.05 0.47 0.11
LY 0.50 0.07 1.21 0.19 0.45 0.06 0.74 0.12 0.41 0.06 0.76 0.13
MO 0.28 0.06 0.02 0.00 0.39 0.07 0.02 0.00 0.21 0.05 0.02 0.00
EO 0.45 0.07 0.10 0.02 0.42 0.06 0.14 0.02 0.38 0.06 0.16 0.03
BA 0.23 0.06 0.001  <0.001 0.25 0.06 0.002  <0.001 0.25 0.06 0.002  <0.001
ADG3 0.44 0.07 0.08 0.01
Health records3 0.07 0.05 0.08 0.06
Lung score3 0.06 0.04 0.07 0.05
1Traits are white blood cells (WBC), neutrophils (NE), lymphocytes (LY), monocytes (MO), eosinophils (EO), and basophils (BA).
2Add_Var = additive variance for each trait.
3The delta measurement was not used for ADG, diagnosis, and lung score. These were measured at differing time points, as discussed in the Materials and 
Methods section.
Table 5. Genetic correlations of pre- and postbooster 
vaccination measurements of blood phenotypes
Trait1 Pre vs. post r2 SE
WBC 0.65*** 0.07
NE 0.72*** 0.08
LY 0.67*** 0.06
MO 0.39* 0.15
EO 0.27* 0.12
BA -0.12 0.20
1Traits are white blood cells (WBC), neutrophils (NE), lymphocytes (LY), 
monocytes (MO), eosinophils (EO), and basophils (BA).
2Pre vs. post r = genetic correlation between the prebooster and postboost-
er trait. *P < 0.05; ***P < 0.001.
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DISCuSSIon
This investigation aimed to discover correlates of 
immunity significantly associated with BRD incidence. 
Discovering correlates affecting BRD incidence after 
vaccination has the potential to help producers alter vac-
cination schedules, isolate animals that are vulnerable to 
infection, and, most importantly, reduce the incidence of 
BRD in a herd by providing heritable targets for genetic 
and, eventually, genomic selection. Further, by defining 
accurate immunological phenotypes, vaccinologists may, 
in turn, be able to design vaccines that benefit weak re-
sponders by investigating the immune responses of suc-
cessfully immunized animals. This investigation moni-
tored the immune response of a herd of crossbred cattle 
during the final stage of vaccination to both viral and bac-
terial causes of BRD. The immune response, as measured 
by counts of white blood cell populations, was found to 
be highly variable and heritable during this period, which 
has been highlighted in different herds using different 
vaccines/immunizations and phenotypes (Kalina et al., 
2005; Leach et al., 2010, 2012). Using genetic models to 
attribute the phenotypic variation to genetic components 
has enabled this study to suggest possible correlates to 
immune responses, which may allow selection for ani-
mals that are more resistant to BRD after vaccination.
Both the innate and the adaptive immune responses 
play a role in vaccination to ensure that a long-lasting 
immunologic memory is formed. Although the immune 
response variables measured in the current study were 
nonspecific to the vaccines used, they do highlight the 
processes of the immune system during vaccination to 
BRD. Further, as similar response profiles were record-
ed each year of vaccination, the results suggest that the 
responses observed during this study were elicited by 
the vaccines used.
The innate immune system has evolved to target 
and remove bacterial and viral pathogens. Detection of 
such pathogens, within the innate immune system, is 
nonspecific. Thus, cells of the innate immune system 
have evolved receptors such as pathogen recognition 
receptors to detect pathogen-associated molecular pat-
terns (Werling and Jungi, 2003; Akira et al., 2006) and 
Fc receptors to detect antibody-bound viral and bacte-
rial particles (Janeway et al., 2005). Three cell types of 
the polymorphonuclear cell family, which contribute to 
the innate immune response, were measured in the cur-
rent study (neutrophils, basophils, and eosinophils). All 
3 cell types contain receptors to interact with specific 
antibody isotypes and cytokines released during an im-
mune response (Paape et al., 2003; Ackermann et al., 
2010; Tizard, 2012). A significant increase in these cell 
types was observed in our results after BRD vaccina-
tion. Thus, although the lymphocytes response was on 
average declining, parts of the innate immune system 
were still increasing. As the half-life of granulocytes is 
relatively short (Carlson and Kaneko, 1975) and neu-
trophils are a swift-acting part of the innate immune 
response, often migrating to the location of infection 
within 1 h to engage with bacterial pathogens (Paape et 
al., 2003), we suggest that these cell types were actively 
engaging either one or both of the vaccines. In addition, 
a review of the current literature in humans has shown 
Table 6. Genetic correlations of blood phenotypes pre- 
and postbooster vaccination and the changes between 
them (delta) with ADG, health records, and lung score
 
Trait1
ADG  Health record  Lung score
r SE r SE  r SE
Pre_WBC -0.05 0.12 0.10 0.26 0.20 0.32
Post_WBC -0.20 0.12 -0.44 0.24 0.19 0.31
Delta_WBC -0.14 0.13 -0.50* 0.24 -0.06 0.34
Pre_NE 0.04 0.13 -0.36 0.28 0.10 0.32
Post_NE -0.10 0.13 -0.52 0.27 -0.19 0.31
Delta_NE -0.20 0.16 -0.16 0.33 -0.28 0.39
Pre_LY -0.08 0.12 0.48 0.25 0.21 0.32
Post_LY -0.24* 0.12 -0.26 0.23 0.56 0.35
Delta_LY -0.12 0.12 -0.67** 0.21 0.22 0.3
Pre_MO -0.17 0.17 -0.33 0.33 0.36 0.45
Post_MO -0.10 0.14 -0.14 0.28 0.50 0.33
Delta_MO 0.00 0.16 0.12 0.32 0.29 0.37
Pre_EO -0.08 0.13 -0.67* 0.29 -0.03 0.33
Post_EO 0.00 0.13 -0.23 0.27 -0.38 0.32
Delta_EO 0.05 0.13 0.16 0.27 -0.39 0.34
Pre_BA -0.04 0.18 -0.14 0.35 -0.22 0.43
Post_BA -0.05 0.15 0.33 0.3 -0.64 0.36
Delta_BA -0.04 0.15 -0.23 0.27 -0.52 0.37
Lung score -0.15 0.33 0.16 0.59
Diagnosis 0.25 0.27
*P < 0.05; **P < 0.01.
1Traits are white blood cells (WBC), neutrophils (NE), lymphocytes (LY), 
monocytes (MO), eosinophils (EO), and basophils (BA), where pre_ = trait 
measured when booster vaccinations were administered, post_ = trait mea-
sured 21 d after booster vaccinations, and delta_ = post time point minus pre 
time point.
Table 7. Genetic correlations1 between changes in (delta) 
blood phenotype pre- and postbooster vaccination
Delta blood 
phenotypes2
Delta blood phenotypes
WBC NE LY MO EO BA
WBC 0.05 0.04 0.13 0.10 0.15
NE 0.86*** 0.11 0.19 0.15 0.18
LY 0.86*** 0.75*** 0.14 0.12 0.12
MO 0.37** -0.05 0.09 0.08 0.12
EO 0.43*** 0.17 -0.05 0.87*** 0.06
BA -0.10 -0.36* -0.48*** 0.71*** 0.81***
1Below the diagonal shows the genetic correlation coefficient; above the 
diagonal shows the SE. t tests were conducted to obtain P-values (*P <  0.05; 
**P <  0.01; ***P <  0.001).
2The blood phenotypes are white blood cells (WBC), neutrophils (NE), 
lymphocytes (LY), monocytes (MO), eosinophils (EO), and basophils (BA).
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that eosinophils also play an active role in modulating 
a Th2-mediated response (Kita, 2011). There is a close 
resemblance between the bovine and human immune 
responses (Goddeeris, 1998). Thus, a similar role may 
be occurring within the current study, with eosinophils 
having an active part in modulating the role of the lym-
phocytes during this immune response.
The average decrease in the lymphocytes suggests 
that the adaptive immune response to the vaccines was 
declining by the second time point, having had ample 
time to produce a response with the possibility of im-
munological memory. However, when investigating 
the additive genetic correlation between pre and post 
phenotypes, lymphocytes showed a significant positive 
correlation. Several animals did increase or maintain 
lymphocytes concentrations throughout both mea-
surements. These animals may be allocating more re-
sources to immune function (negative correlation with 
ADG) and are likely less susceptible to BRD (based on 
negative HR correlation) after vaccination.
Estimates of heritability for BRD infection (using 
HR or LS) remain low (Muggli-Cockett et al., 1992; 
Snowder et al., 2005). The low estimates are largely 
caused by the phenotypes used to record BRD inci-
dence. Bishop and Woolliams (2010) have shown that 
heritability may be underestimated because broad-based 
phenotypes (such as the binary traits used in the cur-
rent study) cannot account for all the different types of 
pathogens that cause infection. Additionally, there are 
often errors in coding healthy animals as diseased and 
diseased animals as healthy. Both misclassifications se-
verely impact the heritability estimated from diagnoses. 
Indeed, the outcome of this study has also shown low 
estimates of heritability (0.06 and 0.07 for LS and HR, 
respectively). The immune response phenotypes were 
estimated to have much higher heritabilities. However, 
these responses were measured very accurately during a 
short time frame (during vaccination, which should elic-
it an immune response). The higher heritabilities and the 
magnitude of their genetic correlation with HR suggest 
these blood phenotypes could be candidates for indicator 
traits in genetic and genomic evaluations.
During this investigation we aimed to identify 
measurable immunological phenotypes that signifi-
cantly changed during vaccination and had a positive 
effect on BRD incidence. A method we chose to do this 
tested for significant genetic correlates of ADG, HR 
(until slaughter), and LS (at harvest) with the immune 
responses measured.
Although measuring the LS at harvest maybe cost 
and labor prohibitive, correlations have been reported 
between lung ultrasonography and respiratory disease 
in cattle (Rabeling et al., 1998; Flock, 2004). Thus, the 
use of ultrasonography to detect lung lesions in cattle 
Table 8. Predicted breed means for each of the blood phenotypes pre- and postbooster vaccination and the changes 
between them (delta), ADG, lung score, and health records1
Trait2 Angus SE Hereford SE Red Angus SE Brahman SE Charolais SE Gelbvieh SE Limousin SE Simmental SE
Pre_WBC 10.66 1.74 10.52 1.70 12.11 1.66 11.07 2.68 12.45 1.75 11.41 1.73 11.73 1.69 10.03 1.78
Post_WBC 10.25 1.46 9.28 1.43 10.44 1.39 11.96 2.24 11.19 1.46 10.91 1.45 10.52 1.42 9.93 1.50
Delta_WBC -0.59 1.68 -1.39 1.64 -1.77 1.61 0.29 2.49 -1.32 1.69 -0.59 1.67 -1.32 1.64 -0.14 1.72
Pre_NE 2.93 0.81 2.68 0.80 3.13 0.78 2.25 1.24 3.48 0.82 3.15 0.81 2.45 0.79 3.31 0.83
Post_NE 2.63 0.76 2.77 0.74 3.24 0.72 2.45 1.15 2.92 0.76 3.62 0.75 2.36 0.74 3.29 0.78
Delta_NE -0.29 0.89 0.08 0.87 0.16 0.85 -0.05 1.27 -0.44 0.90 0.47 0.89 -0.04 0.87 0.10 0.91
Pre_LY 5.73 1.02 6.24 1.00 6.71 0.98 7.11 1.59 6.66 1.03 6.49 1.02 7.40 1.00 5.22 1.05
Post_LY 4.97 0.84 4.64 0.82 4.89 0.80 5.31 1.29 5.50 0.84 4.54 0.83 5.77 0.82 4.15 0.86
Delta_LY -0.82 0.89 -1.68 0.87 -1.89 0.85 -1.94 1.35 -1.22 0.90 -1.97 0.89 -1.70 0.87 -1.10 0.92
Pre_MO 0.68 0.16 0.60 0.16 0.80 0.15 0.79 0.23 0.64 0.16 0.45 0.16 0.71 0.16 0.42 0.16
Post_MO 0.65 0.14 0.46 0.14 0.51 0.14 0.81 0.22 0.50 0.15 0.45 0.14 0.54 0.14 0.34 0.15
Delta_MO -0.07 0.18 -0.16 0.17 -0.31 0.17 -0.02 0.25 -0.16 0.18 -0.01 0.18 -0.18 0.17 -0.09 0.18
Pre_EO 1.33 0.31 0.98 0.30 1.40 0.29 0.88 0.47 1.61 0.31 1.34 0.30 1.14 0.30 1.10 0.31
Post_EO 1.88ab 0.38 1.36a 0.37 1.67ab 0.36 2.95b 0.58 2.17ab 0.38 2.14ab 0.38 1.75ab 0.37 2.01ab 0.39
Delta_EO 0.51a 0.42 0.35a 0.41 0.25a 0.40 2.00b 0.63 0.53ab 0.42 0.77ab 0.42 0.58ab 0.41 0.88ab 0.43
Pre_BA 0.07 0.03 0.04 0.03 0.07 0.03 0.06 0.05 0.07 0.03 0.04 0.03 0.05 0.03 0.02 0.03
Post_BA 0.11a 0.06 0.06a 0.05 0.09a 0.05 0.32b 0.08 0.11a 0.06 0.12a 0.06 0.10a 0.05 0.14ab 0.06
Delta_BA 0.04a 0.06 0.02a 0.06 0.02a 0.06 0.26b 0.09 0.03a 0.06 0.08ab 0.06 0.05a 0.06 0.11ab 0.06
ADG 3.58 0.46 3.72 0.45 3.76 0.45 3.11 0.55 3.47 0.46 3.43 0.46 3.52 0.45 3.57 0.46
Diagnosis -3.58 1.23 -2.10 1.15 -3.05 1.18 –4.70 1.52 -3.44 1.23 -3.23 1.20 -2.95 1.18 -3.13 1.21
Lung Score 2.12 1.03 1.19 0.93 0.30 0.92 0.60 1.14 1.03 0.97 1.26 0.95 0.85 0.93 0.70 0.96
1Within a row means with different superscripts are different (P < 0.05).
2The traits are white blood cells (WBC), neutrophils (NE), lymphocytes (LY), monocytes (MO), eosinophils (EO), and basophils (BA), where pre_ = trait 
measured when booster vaccinations were administered, post_ = trait measured 21 d after booster vaccinations, and delta_ = post time point minus pre time point.
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to identify either current or previous interactions with 
a BRD pathogen is possible. Unfortunately, no signifi-
cant correlation existed between the lung lesions and the 
immune responses in this study, suggesting the immune 
response measures in this study are poor predictors of 
the propensity of cattle to have long-term lung damage. 
Many reasons could account for the unexpected non-
significant correlation. In the current study, the immune 
response was only measured for a relatively short time 
course containing only 2 time points. Thus, the change 
in the immune response may occur before or after the 
booster vaccination. Another possibility highlights the 
specificity of the immune phenotypes measured. In the 
current study, broad blood-based components of both the 
innate and adaptive immune responses were measured. If 
a more targeted phenotype (e.g., alveolar macrophages) 
that plays a role in BRD detection, and possibly pathol-
ogy, within the lungs (Ackermann et al., 2010) were used, 
a significant correlation might have become apparent.
The current study found no evidence of a significant 
correlation between lung lesion and BRD incidence. An 
issue with the correlation appears to be the crossover 
between the distributions. For example, 76% of the ani-
mals that were diagnosed did indeed have lesions in the 
lung, which indicates a premise for correlation. However, 
87% of animals that had lung lesions were diagnosed 
as healthy (with respect to BRD). Other studies have 
shown similar trends with a large number of untreated 
animals also having lung lesions (38% to 68%;Wittum 
et al., 1996; Bryant et al., 1999; Thompson et al., 2006; 
Schneider et al., 2009); however, the percentage we 
present is considerably greater. Much of the error may 
have come from the method used to record lung lesions. 
Other studies used specific areas of the lung to calcu-
late lung lesions. They also used discrete rather than 
binomial distributions, enabling more power to detect 
correlations with health trait records. Unfortunately, the 
current study did not because of the speed required to 
record lung lesions on a large number of animals. Thus, 
because of the lack of specificity and the overall trait 
type (which has low heritability), detecting significant 
genetic correlation using the techniques outlined in this 
investigation would require many more animals.
The delta responses of the WBC and lymphocytes 
were negatively correlated with HR. Thus, selection to 
increase lymphocytes and WBC deltas should improve 
BRD health overall after vaccination. The results also 
showed that animals genetically predisposed to have 
greater pre lymphocytes concentrations had a greater 
probability of remaining healthy with respect to BRD. 
Thus, the successful immunization of animals (within 
this herd) appears to be a function of a greater concentra-
tion of pre lymphocytes and a low rate of decline (or no 
decline) of WBC and lymphocytes 21 d after the booster 
vaccination is administered. Potentially, a function of 
these phenotypes could be used to segregate success-
fully vaccinated animals from those that need further 
vaccination or quarantine. Further, breeding programs 
may be able to add these phenotypes to breeding indices 
to reduce the overall incidence of BRD within a herd or 
as target traits in genomic selection given the reduced 
efficacy of using HR alone.
Producing a delta measurement of lymphocytes (or 
any of the blood phenotypes used in the current study) 
requires a significant amount of time, resources, and 
equipment to accurately quantify cell-type concentra-
tions from blood collected from animals at booster vac-
cination and 21 d later. With the use of modern genom-
ics this phenotype might not need to be measured every 
generation (Hayes et al., 2009). If animals are geno-
typed, markers in the genome can be tested for signifi-
cant associations with phenotypes (delta lymphocytes in 
this instance). As a result, selection of favorable cattle 
in subsequent generations could occur at birth, vastly 
speeding up generation intervals. We believe that ge-
nomic selection shown in the dairy industry (Hayes et 
al., 2009) would also apply to selection of cattle that re-
spond to vaccines with perceived immunity. Thus, the 
money spent collecting highly heritable and correlated 
indicator phenotypes, such as these, would be a valuable 
investment into the genomic advancement of a herd, re-
ducing the incidence of BRD post vaccination.
Many studies have shown a negative correlation be-
tween animals that are “infected with” or “treated for” 
BRD and ADG even during treatment (Bateman et al., 
1990; Jim et al., 1993; Wittum et al., 1996; Thompson 
et al., 2006; Schneider et al., 2009). The current study, 
however, discovered the opposite, an insignificant cor-
relation between BRD and ADG. It is likely this rela-
tionship depends on the level of BRD affecting the herd; 
under high challenge, increased immune function may 
divert energy from growth. Indeed, the current study did 
have many negative correlations with ADG; however, 
the only significantly negative correlation was estimated 
between post lymphocytes and ADG, thereby indicating 
that as the number of lymphocytes increases, the ADG 
decreases. Thus, the animals within the herd may have 
been diverting energy from growth to eliciting immune 
responses. This will have a negative impact on cost of 
production (as number of days fed to slaughter will in-
crease). However, from these results we suggest the 
possibility that any immune response may reduce ADG 
(nonspecific immune responses were measured during 
the current study); thus, an immune response elicited 
from a vaccine at a controlled time point and at a con-
trolled dose should give animals the best possible chance 
to form immunological memory and minimally affect 
ADG. Also, the prevalence in the beef industry suggests 
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that this lower genetic potential for ADG may be a fair 
compromise. Further, changes in the age of vaccination 
may potentially alter the negative correlation. In addition, 
it appears that HR and, to a lesser extent LS, may be used 
as a diagnostic tool. For example, the use of the delta 
lymphocyte phenotype as a correlate for later health rela-
tive to BRD may enable producers to target animals that 
may have responded to BRD vaccination poorly.
The immune response to infection is variable be-
tween breeds (Morris, 2007). Further, breed analysis of 
the incidence of BRD has shown some significant dif-
ferences between breeds (Snowder et al., 2006). Within 
the current study the results indicated 1 major difference 
among the breeds. Brahman was significantly different 
from all other breeds for at least 1 phenotype, with the 
exception of Simmental. Thus, the major difference ap-
pears to be in the differential way a Bos taurus animal 
elicits an immune response compared with a Bos indi-
cus–cross animal. Each significant difference in breed 
response shows the Brahman breed eliciting a greater re-
sponse. Further research with more Bos indicus breeds 
(the current study contains only 1) is needed to further 
validate the differences between the 2 subspecies using 
these immune variables. However, our results do indi-
cate that animals with a greater number of eosinophils 
(which was significantly different between breeds) are 
treated less commonly for BRD post vaccination. Thus, 
the significant differences between Bos taurus and 
Bos indicus may indicate how a favorable immune re-
sponse is elicited in cattle. These results may also be 
due to breed-specific heterosis (i.e., greater heterosis 
for Bos indicus crosses) rather than a strict breed effect. 
However, this herd is not ideal for picking out breed-
specific differences as the majority of animals contained 
within are only a quarter to a half of any 1 breed. This 
makes breed comparisons difficult and may explain why 
ADG was very similar across the multiple breeds.
Much is still unknown about the genetic effects be-
hind the immune response. In this investigation we have 
added to the growing body of research that is currently 
investigating the genetic effects behind successful vac-
cination for BRD. We have shown a significant genetic 
correlation of eosinophils count before booster vaccina-
tion with HR after vaccination. We have also shown that 
changes in WBC and lymphocyte concentrations during 
the booster phase of vaccination are correlated with the 
ongoing health of an animal and the potential for genetic 
selection based on immune response. Further, we have 
shown that components of the innate immune response 
appear to be actively increasing during the booster phase, 
and this also correlates with the health of the animal.
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